NDC 53666-403-33 - Alka Seltzer
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 53666-403
- Requested NDC
- 53666-403-33
- Package NDCs from labels
- 53666-403-33, 53666-403-15
- Manufacturer
- Salimex, S.A. | Bayer de Mexico, S.A. de CV
- Effective date
- 2012-11-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Alka Seltzer - Salimex, S.A. | Bayer de Mexico, S.A. de CV | Salimex, S.A. | Bayer de Mexico, S.A. de CV | 2012-11-09 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53666-403-15 | 2021-01-29 | C162847 | 48780-1 | 9855d018-d559-cd31-e053-dbdaa90ab51a | Alka Seltzer |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53666-403-15 | Alka Seltzer | 150 in 1 CASE | TABLET, EFFERVESCENT | 150 | 3 | |
| 53666-403-33 | Alka Seltzer | 12 in 1 BOX | TABLET, EFFERVESCENT | 12 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ANHYDROUS CITRIC ACID | ACTIVE INGREDIENT | XF417D3PSL | ALKA SELTZER (ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE) TABLET, EFFERVESCENT [SALIMEX, S.A.] | 3 | |
| ASPIRIN | ACTIVE INGREDIENT | R16CO5Y76E | ALKA SELTZER (ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE) TABLET, EFFERVESCENT [SALIMEX, S.A.] | 3 | |
| SODIUM BICARBONATE | ACTIVE INGREDIENT | 8MDF5V39QO | ALKA SELTZER (ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE) TABLET, EFFERVESCENT [SALIMEX, S.A.] | 3 | |
| ANHYDROUS CITRIC ACID | ACTIVE MOIETY | XF417D3PSL | ALKA SELTZER (ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE) TABLET, EFFERVESCENT [SALIMEX, S.A.] | 3 | |
| ASPIRIN | ACTIVE MOIETY | R16CO5Y76E | ALKA SELTZER (ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE) TABLET, EFFERVESCENT [SALIMEX, S.A.] | 3 | |
| BICARBONATE ION | ACTIVE MOIETY | HN1ZRA3Q20 | ALKA SELTZER (ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE) TABLET, EFFERVESCENT [SALIMEX, S.A.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen 250 mg Aspirin 250 mg Caffeine 65 mg | ACETAMINOPHEN 250 MG ASPIRIN 250 MG CAFFEINE 65 MG | Health Pharma USA LLC | 3590d417-272b-ae4d-e063-6394a90a5dc6 | 2026-07-08 | Warnings | R16CO5Y76E |
| Pain Reliever Plus | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Rugby Laboratories | c3df1652-96a8-6043-e053-2995a90a2d26 | 2026-07-07 | Warnings | R16CO5Y76E |
| Rapidol Aspirin | ASPIRIN | Pharmadel LLC | 00d9ab0d-ff25-784f-e063-6294a90a8497 | 2026-07-06 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Trifecta Pharmaceuticals USA LLC | 227cefca-acc4-41d0-e063-6394a90a35b9 | 2026-07-06 | Warnings | R16CO5Y76E |
| Extra Strength Pain Aid | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Hi-Tech Nutaceuticals, LLC | a39e4b99-700d-0f5c-e053-2a95a90a6bd3 | 2026-07-06 | Warnings | R16CO5Y76E |
| PAIN RELIEVER | ASPIRIN 81 MG | Health Pharma USA, LLC | d60aed37-3a9e-46d1-e053-2995a90a1d1f | 2026-07-06 | Warnings | R16CO5Y76E |
| Bayer Genuine Aspirin | ASPIRIN | Select Consumer Group | 3ca776c2-47ed-5107-e063-6394a90ac5df | 2026-07-03 | Warnings | R16CO5Y76E |
| Excedrin Migraine | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Select Consumer Group | 3caa4adf-abe3-67c3-e063-6294a90a87a4 | 2026-07-03 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Rugby Laboratories | f7ca9f4a-f8ef-46d2-9536-b69541e6653d | 2026-07-02 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | United Natural Foods, Inc. dba UNFI | 19c7f832-d7ec-4dcc-8aa4-f4cbf64c9ff6 | 2026-07-02 | Warnings | R16CO5Y76E |
| Aspirin 325 mg | ASPIRIN | Hi-Tech Nutraceuticals, LLC | b3426a9a-ea99-da30-e053-2995a90a1e4b | 2026-07-01 | Warnings | R16CO5Y76E |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Salado Sales, Inc. | ca21d576-be3c-495d-9dbd-ed514bf65da7 | 2026-07-01 | Warnings | R16CO5Y76E |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Wal-Mart Stores Inc | 9b1201af-c802-4e19-b192-bbbf34367db4 | 2026-06-30 | Warnings | R16CO5Y76E |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | United Natural Foods, Inc. dba UNFI | b6ff2b34-51ee-41bc-8b7d-7520ade0bf36 | 2026-06-30 | Warnings | R16CO5Y76E |
| Medline | ASPIRIN | Medline Industries, LP | 4b0c569a-ed7a-e104-e063-6394a90a6d54 | 2026-06-29 | Warnings | R16CO5Y76E |
| SODIUM BICARBONATE | SODIUM BICARBONATE | HF Acquisition Co LLC, DBA HealthFirst | 9ee46a5b-d00e-4254-e053-2995a90aeb3a | 2026-06-29 | Warnings, Adverse reactions | 8MDF5V39QO |
| Aspirin | ASPIRIN | Strategic Sourcing Services LLC | ea2ef485-429e-4c63-ba7b-0a6b32892ad2 | 2026-06-25 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Chain Drug Marketing Association, Inc. | 055d8420-c189-4a9e-acdc-21627935c8eb | 2026-06-25 | Warnings | R16CO5Y76E |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BOVISTA, CARBO VEGETABILIS, CARBONEUM SULPHURATUM, COFFEA CRUDA, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SULPHUR, ACETYLSALICYLICUM ACIDUM, FORMALINUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, TEREBINTHINA, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, | Energique, Inc. | 2e361b50-9268-4053-b13c-93af64549848 | 2026-06-25 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Topco Associates, LLC | 5f32cf74-dbea-496c-ba23-2040ea354f40 | 2026-06-25 | Warnings | R16CO5Y76E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.